Stock IdeasStrong Buy StocksStrong Buy Stocks from Top Wall Street AnalystsLatest stocks with a Strong Buy rating from the top performing 25% of analysts tracked by WallStreetZen
Stock IdeasStrong Buy Stocks
| Analyst / Firm | Company | Price | Rating | Price Target | Upside/Downside | Date |
|---|---|---|---|---|---|---|
Ascendis Pharma AASND | $174.96 | Strong Buy | $243.00 | +38.89% | 16 hours ago | |
Analyst RankingTop 26% #1299 out of 4937 analysts Average Return+1.79% Win Rate50%57 out of 115 Risk vs RewardPoor Good Analyst ColorCitigroup's David Lebovitz raised their price target on Ascendis Pharma A (NASDAQ: ASND) by 14.1% from $213 to $243 on 2025/07/11. The analyst maintained their Strong Buy rating on the stock. Lebovitz attributed their price target hike on Ascendis Pharma A to Citigroup updating its estimates on commercial-stage biotechnology names ahead of earnings season. | ||||||
Tesla IncTSLA | $800.00 | Strong Buy | $850.00 | +6.25% | a day ago | |
Upgrade to Premium to View MoreStrong buys: Upgrade to Premium to view the rest of today's Strong Buy stocks from Wall Street's top analysts Already have a premium account? Sign In | ||||||
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.